Capitol Hill Whither ARPA-H? What can Biden’s agency do that cancer centers can’t? May 06, 2022Vol.48 No.18By Paul Goldberg
Drugs & Targets Portage Biotech, NCI, Stimunity enter cooperative R&D agreement to develop STING agonists and anti-RAGE agents for cancer vaccines April 29, 2022Vol.48 No.17
Conversation with The Cancer LetterFree Ned Sharpless steps down as NCI director April 08, 2022Vol.48 No.14By Matthew Bin Han Ong and Paul Goldberg
White House Biden’s FY23 proposal cuts NCI funds by $199M, while boosting ARPA-H by $4B April 01, 2022Vol.48 No.13By Alice Tracey and Paul Goldberg
NCI Sharpless: You have to be an optimist to be an oncologist April 01, 2022Vol.48 No.13By Matthew Bin Han Ong
Clinical Roundup NCI launches program for molecular characterization of childhood cancers March 25, 2022Vol.48 No.12
Conversation with The Cancer LetterWhite House White House’s Danielle Carnival: I’m moving the Cancer Moonshot forward with an all-of-government approach February 18, 2022Vol.48 No.07By Matthew Bin Han Ong
